IL-10 producing CD14low monocytes inhibit lymphocyte-dependent activation of intestinal epithelial cells by commensal bacteria

Microbiology and Immunology

Volumn 46, Issue 3, 2002, Pages 195-205

  Haller, Dirk ^a,c   Serrant, Patrik ^a   Peruisseau, Genneviève ^a   Bode, Christiane ^b   Hammes, Walter P ^b   Schiffrin, Eduardo ^a   Blum, Stephanie ^a  

^a NESTLÉ RESEARCH CENTER   (Switzerland)

^b UNIVERSITY OF HOHENHEIM   (Germany)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

CaCO 2 and HT 29 transwell co cultures; CD14low CD16low monocytes; Commensal bacteria; IL 10; IL 8; Intestinal epithelial cells; Lactobacilli; TNF

Indexed keywords

B7 ANTIGEN; CD14 ANTIGEN; CD16 ANTIGEN; CD86 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 8; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN EXPRESSION; ARTICLE; CELL ACTIVATION; CELL CULTURE; CELL POPULATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; GRAM POSITIVE BACTERIUM; HOMEOSTASIS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; INTESTINE EPITHELIUM CELL; INTESTINE FLORA; LACTOBACILLUS; LYMPHOCYTE ACTIVATION; MONOCYTE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTIGENS, CD14; BIOLOGICAL MARKERS; CACO-2 CELLS; COCULTURE TECHNIQUES; DOWN-REGULATION; EPITHELIAL CELLS; ESCHERICHIA COLI; HT29 CELLS; HUMANS; INTERLEUKIN-10; INTESTINAL MUCOSA; LACTOBACILLUS; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTES; MONOCYTES; RECEPTORS, IGG; TIME FACTORS;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; LACTOBACILLUS; LACTOBACILLUS SAKEI; NEGIBACTERIA; POSIBACTERIA;

EID: 0036214504     PISSN: 03855600     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2002.tb02686.x     Document Type: Article

References (58)

1. Changes in phenotypically distinct mucosal macrophage populations may be a prerequisite for the development of inflammatory bowel disease
2. In situ expression of interleukin-10 in noninflamed human gut and in inflammatory bowel disease
3. Shedding as a mechanism of down-modulation of CD14 on stimulated human monocytes
4. Immunological responses and microorganisms indigenous to the gastrointestinal tract
5. Expression of a nonpolymorphic MHC class I-like molecule, CD1D, by human intestinal epithelial cells
6. + monocytes in human sepsis: A case report of a patient with self-induced septicemia
7. Difference in the blood monocyte phenotype between uremic patients and healthy controls: Its relation to monocyte differentiation into macrophages in the peritoneal cavity
8. Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic intestinal inflammation
9. Influences of microbiota on intestinal immune system development
10. Acute colitis produced by chemotactic peptides in rats and mice
11. Human intestinal epithelial cell lines produce factor(s) that inhibit CD3-mediated T-lymphocyte proliferation
12. − T cells reactive to enteric bacterial antigens in spontaneously colitic C3H/HeJBir mice: Increased T helper cell type 1 response and ability to transfer disease
13. Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease
14. A medium for the cultivation of lactobacilli
15. Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum
16. The structure of the colonic mucosa. The epithelium and subepithelial reticulohistiocytic complex
17. Distinct scavenger receptor expression and function in the human CD14(+)/CD16(+) monocyte subset
18. Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD)
19. T cell specificity and cross reactivity towards enterobacteria, bacteroides, bifidobacterium, and antigens from resident intestinal flora in humans
20. Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interleukin-10 or antibodies to interleukin-12
21. + blood monocytes is expanded in sepsis patients
22. + population of monocytes in inflammatory bowel disease mucosa - Implications for pathogenesis
23. Direct evidence of monocyte recruitment to inflammatory bowel disease mucosa
24. Activation of human peripheral blood mononuclear cells by nonpathogenic bacteria in vitro: Evidence for NK cells as primary targets
25. Non-pathogenic bacteria elicit a differential cytokine response by intestinal epithelial cell/leucocyte co-cultures
26. A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion
27. Epithelial cells as sensors for microbial infection
28. Observations on the reaction of the intestinal mucosa to bacterial challenge
29. Colon carcinoma cell lines stimulate monocytes and lamina propria mononuclear cells to produce IL-10
30. Expression patterns of Fc gamma receptors, HLA-DR and selected adhesion molecules on monocytes from normal and HIV-infected individuals
31. Effector and regulatory lymphoid cells and cytokines in mucosal sites
32. A primitive T cell-independent mechanism of intestinal mucosal IgA responses to commensal bacteria
33. Expression of leukocyte adhesion molecules by mucosal mononuclear phagocytes in inflammatory bowel disease
34. Salmonella typhimurium attachment to human intestinal epithelial monolayers: Transcellular signalling to subepithelial neutrophils
35. Interleukin-10
36. Intestinal epithelial cells down-regulate macrophage tumor necrosis factor-alpha secretion: A mechanism for immune homeostasis in the gut-associated lymphoid tissue
37. Cyclooxygenase-2-dependent arachidonic acid metabolites are essential modulators of the intestinal immune response to dietary antigen
38. Interaction of T cells with allogeneic macrophages in mixed leukocyte cultures in rats
39. The regulation and functional consequence of proinflammatory cytokine binding on human intestinal epithelial cells
40. Distribution of human colonic dendritic cells and macrophages
41. Microbial-host interactions at mucosal sites. Host response to pathogenic bacteria at mucosal sites
42. Enhanced mucosal cytokine production in inflammatory bowel disease
43. Human intestinal mucosa alters T-cell reactivities
44. Differential regulation of human T cell responsiveness by mucosal versus blood monocytes
45. Activation and signaling status of human lamina propria T lymphocytes
46. Isolation and phenotypic characterization of colonic macrophages
47. Differential distribution of B7.1 (CD80) and B7.2 (CD86) costimulatory molecules on mucosal macrophage subsets in human inflammatory bowel disease (IBD)
48. Increased macrophage subset in inflammatory bowel disease: Apparent recruitment from peripheral blood monocytes
49. + monocyte derived cells
50. Cytokine profiles differ in newly recruited and resident subsets of mucosal macrophages from inflammatory bowel disease
51. Pathogenesis and immune mechanisms of chronic inflammatory bowel disease
52. Immunoregulatory role of interleukin-10 in patients with inflammatory bowel disease
53. Increased activation of isolated intestinal lamina propria mononuclear cells in inflammatory bowel disease
54. Increased in vitro release of soluble interleukin-2 receptor by colonic lamina propria mononuclear cells in inflammatory bowel disease
55. Phlogistic properties of peptidoglycan-polysaccharide polymers from cell walls of pathogenic and normal-flora bacteria which colonize humans
56. Monocyte differentiation in intestine-like macrophage phenotype induced by epithelial cells
57. Spontaneous, heritable colitis in a new substrain of C3H/HeJ mice
58. Definition of a lamina propria T cell responsive state. Enhanced cytokine responsiveness of T cells stimulated through the CD2 pathway